Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)
12.20
+0.25
(+2.05%)
Streaming Delayed Price
Updated: 11:10 AM EST, Nov 24, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 968,369 |
| Open | 11.99 |
| Bid (Size) | 12.19 (1,000) |
| Ask (Size) | 12.20 (800) |
| Prev. Close | 11.95 |
| Today's Range | 11.93 - 12.24 |
| 52wk Range | 6.685 - 12.12 |
| Shares Outstanding | 1,000 |
| Dividend Yield | N/A |
Top News
More News
Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know
November 21, 2025
Via StockStory
Topics
Economy
Performance
| YTD |
+57.2%
|
+57.2%
|
| 1 Month |
+15.6%
|
+15.6%
|
| 3 Month |
+31.4%
|
+31.4%
|
| 6 Month |
+67.3%
|
+67.3%
|
| 1 Year |
+45.5%
|
+45.5%
|
More News
Read More
Earnings Scheduled For October 30, 2025 ↗
October 30, 2025
Via Benzinga
3 Russell 2000 Stocks with Warning Signs
November 13, 2025
Via StockStory
Amneal Receives U.S. FDA Approval for Iohexol Injection
November 13, 2025
Via GlobeNewswire
3 Stocks Under $50 We Steer Clear Of
November 11, 2025
Via StockStory
3 Value Stocks We Find Risky
November 09, 2025
Via StockStory
Why Amneal (AMRX) Stock Is Up Today
October 31, 2025
Via StockStory
Amneal (NASDAQ:AMRX) Beats Q3 Sales Expectations, Stock Soars
October 30, 2025
Via StockStory
Amneal Reports Third Quarter 2025 Financial Results
October 30, 2025
Via GlobeNewswire
Amneal Earnings: What To Look For From AMRX
October 28, 2025
Via StockStory
Topics
Artificial Intelligence
3 Cash-Producing Stocks with Questionable Fundamentals
October 27, 2025
Via StockStory
3 of Wall Street’s Favorite Stocks We Find Risky
October 14, 2025
Via StockStory
Via Benzinga
1 Small-Cap Stock with Competitive Advantages and 2 We Turn Down
October 09, 2025
Via StockStory
Via Business Wire
3 Lesser-Known Healthcare Names With Major Upside in Store ↗
October 02, 2025
Via MarketBeat
Amneal to Report Third Quarter 2025 Results on October 30, 2025
September 30, 2025
Via GlobeNewswire
Via GlobeNewswire
Amneal Pharma Stock Rises On FDA Approval For Generic Version Of AbbVie’s Eyedrops ↗
September 23, 2025
Via Stocktwits
Frequently Asked Questions
Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.20
When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 11/24/25 11:10 AM ET
What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.20K
How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Amneal Pharmaceuticals, Inc. - Class A Common Stock has 12K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>